Santini et al. found that SOX-2 expression is enhanced in melanoma cells with stem cell features33 and the neural crest stem cell marker CD271 expression was shown to be specifically increased in metastatic melanoma to the brain34. The gene discussed is SOX2; the disease is metastatic melanoma.